Zydus Cadila


Zydus Cadila division was created for the therapy area of pain management, anti-hypertensives, anti-ulcerants, hepatology, and multi-vitamins. It is the flagship division of Zydus Healthcare Limited. The division aims to provide innovative healthcare solutions to improve patient care.

Zydus Cadila is a multi-therapy division that has a strong presence in Pain and Analgesics market with the brand NUCOXIA, launched in 2004. Nucoxia is the preferred choice of Orthopedicians for pain management. Other legacy brands in this division include Aten, Ocid, and Falcigo.

Our Leading Brands

Divisional Achievements

Cadila’s Nucoxia brand is recognized as the number 1 brand in Etoricoxib molecule since launch. Nucoxia has been dominating the Etoricoxib market for the last 17 years.

See All Division of Zydus Healthcare Limited